J.M. Cejalvo Andujar

Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression

J.M. Cejalvo Andujar, Francisco Ayala, Mireia Margelí Vila, Javier Pascual et autres

This review offers an expert perspective on biomarkers, CDK4/6 inhibitor efficacy, and therapeutic approaches for managing hormone receptor-positive (HR+), human epidermal growth factor receptor-negative (HER2-) advanced breast cancer (ABC), particularly after CDK4/6 inhibitor progression. Key trials have demonstrated that combining CDK4/6 inhibitors …

es, us (code pays fourni par la source)

202TiP SOLTI-1805 TOT-HER3 trial: A window-of-opportunity trial of patritumab deruxtecan (HER3-DXd) in patients with treatment-naïve, early breast cancer

M. Oliveira, J.M. Cejalvo Andujar, Mireia Margelí Vila, P. Tolosa Ortega et autres

es, us (code pays fourni par la source)

LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial

Aleix Prat, Claudette Falato, Laia Paré Brunet, Olga Martínez‐Sáez et autres

es, us (code pays fourni par la source)

108P Pathologic nodal positivity in patients with cT1-2 cN0 HER2+ breast cancer treated with upfront surgery or neoadjuvant anti-HER2-based therapy

Olga Martínez‐Sáez, C. Hernando Melia, M. Rey, Núria Chic et autres

es (code pays fourni par la source)

299P MicroRNAs-449 regulate doxorubicin response through ACSL4 modulation in TNBC

Stephen Ruiz, Iris Garrido Cano, R. Vidal, C. Hernando Melia et autres

es (code pays fourni par la source)

Nuevas vías moleculares implicadas en los mecanismos de resistencia primaria y adquirida en cáncer de mama her2 positivo

J.M. Cejalvo Andujar

El cancer de mama es el tumor mas frecuente en la mujer, representa aproximadamente el 28% de todas las neoplasias y es la principal causa de muerte por cancer en las mujeres europeas. A pesar de los avances en el tratamiento y …

Effect of vasoactive drugs on muscle fibre types and capillaries.

Sonia H. Torres, Daniel Kaswan, J.M. Cejalvo Andujar, Jenny Valentina Garmendia et autres

The effect of nitroglycerin, nifedipine, diltiazem or propranolol on fibre types and capillaries was studied in extensor digitorum longus (EDL) and soleus (S) muscles of the rat. In EDL muscle nifedipine increased the proportion of type I fibres (7.9% +/- 1.7 vs. …

ve (code pays fourni par la source)